ERBB2 and neoplasm: Fifteen gains in six different chromosomes (2p, 5p, 6p, 11q, 17q, and 18) were more frequently detected (p < 0.01) in TNBC than in hormone receptor-positive and/or HER2+ tumor subtypes (Table S4).